The International Myeloma Foundation says the newest myeloma therapeutic now approved for patients in Canada

12-02-2014 Business Wire HealthComments (0)

BiotechnologyCanadaOncologyPomalyst

The International Myeloma Foundation says Pomalyst approval by Health Canada provides myeloma patients the most up-to-date oral therapy available for patients who have exhausted all other treatments.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top